Transfusion-related acute lung injury (TRALI) digital illustration

Transfusion-related acute lung injury (TRALI) Save


ICD-10 code: J95.84

Disease category: J95.84: Transfusion-related acute lung injury (TRALI)

Understanding Transfusion-Related Acute Lung Injury (TRALI)

Transfusion-Related Acute Lung Injury (TRALI) is a serious condition that can occur as a result of blood transfusions. Although rare, TRALI can lead to severe lung damage and even death, making it crucial to identify and manage the condition promptly.

TRALI typically presents within six hours of receiving a blood transfusion, but the exact cause is not fully understood. It is believed to be an immune reaction triggered by antibodies present in the donated blood, which then attack the patient's lung tissue.

Here are a few key points about TRALI:

  1. Signs and Symptoms: The most common symptoms of TRALI include sudden onset of shortness of breath, rapid breathing, low oxygen levels, and lung congestion. These symptoms can be life-threatening and require immediate medical attention.
  2. Risk Factors: Certain factors may increase the risk of developing TRALI. These include receiving blood products from a female donor who has been pregnant in the past, as well as patients with pre-existing lung diseases or a history of transfusion reactions.
  3. Diagnosis: To diagnose TRALI, healthcare professionals will assess the patient's symptoms, medical history, and perform tests such as chest X-rays, blood tests, and arterial blood gases. It is essential to differentiate TRALI from other lung-related complications of transfusion.
  4. Treatment: The treatment for TRALI aims to support the patient's breathing and oxygenation. This may involve providing supplemental oxygen, administering medications to reduce inflammation, and in severe cases, mechanical ventilation.
  5. Prevention: Preventing TRALI involves careful donor selection and screening. Strategies such as avoiding blood from donors with a history of pregnancy, using male-only plasma, or selecting plasma from multiparous female donors who have been tested for anti-HLA and anti-human neutrophil antigen antibodies can help mitigate the risk.

It is crucial for healthcare professionals and blood banks to be aware of TRALI and take appropriate precautions to minimize the occurrence of this condition. By understanding the risk factors and implementing preventive measures, we can ensure the safety of blood transfusion recipients.

Treatment of Transfusion-related acute lung injury (TRALI):

Treatment Options for Transfusion-related Acute Lung Injury (TRALI)

Transfusion-related acute lung injury (TRALI) is a severe condition that can occur after receiving a blood transfusion. It is characterized by sudden respiratory distress and can be life-threatening. Prompt and appropriate treatment is crucial to mitigate its effects. Here are some treatment options for TRALI:

...

To see full information about treatment please Sign up or Log in